GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chandra Bhagat Pharma Ltd (BOM:542934) » Definitions » Net Income (Continuing Operations)

Chandra Bhagat Pharma (BOM:542934) Net Income (Continuing Operations) : ₹16 Mil (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Chandra Bhagat Pharma Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Chandra Bhagat Pharma's Net Income (Continuing Operations) for the six months ended in Sep. 2024 was ₹7 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹16 Mil.


Chandra Bhagat Pharma Net Income (Continuing Operations) Historical Data

The historical data trend for Chandra Bhagat Pharma's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chandra Bhagat Pharma Net Income (Continuing Operations) Chart

Chandra Bhagat Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Income (Continuing Operations)
Get a 7-Day Free Trial 3.15 1.90 7.97 9.05 15.30

Chandra Bhagat Pharma Semi-Annual Data
Mar17 Mar18 Mar19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.69 5.37 6.35 8.95 6.85

Chandra Bhagat Pharma Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chandra Bhagat Pharma  (BOM:542934) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.


Chandra Bhagat Pharma Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Chandra Bhagat Pharma's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.


Chandra Bhagat Pharma Business Description

Traded in Other Exchanges
N/A
Address
Doctor Ambedkar Road, 323-F Bhagat Bhuvan, Matunga (East), Mumbai, MH, IND, 400019
Chandra Bhagat Pharma Ltd is engaged in the business of marketing pharmaceutical critical care and health care products. The company provides a pharmaceutical formulation in therapeutic categories for formulations such as Anti-cancer (Oncology), Antibiotics, Anesthesia, Hormones, Orthopedic, Cardiac, Cardiovascular, Anti-fungal, Antiviral, Pediatrics, Cardiology, Nephrology, Neurology, and others. It is also engaged in promoting and marketing Active Pharmaceuticals Ingredients (APIs) in India.

Chandra Bhagat Pharma Headlines

No Headlines